These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17334957)

  • 21. Spotlight on rizatriptan in migraine.
    Wellington K; Jarvis B
    CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs.
    Hewitt DJ; Pearlman E; Hämäläinen M; Lewis D; Connor KM; Michelson D; Ceesay P; Assaid C; Bachman R; Harper Mozley L; Dupre N; Strickler N; Mahoney E; Lines C; Ho TW
    Headache; 2013 Jan; 53(1):104-117. PubMed ID: 23078588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.
    Dodick DW; Sandrini G; Williams P
    CNS Drugs; 2007; 21(1):73-82. PubMed ID: 17190530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
    Láinez MJ; Evers S; Kinge E; Allais G; Allen C; Rao NA; Massaad R; Lis K
    Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rizatriptan. Comparative trial results.
    Jamieson DG
    Postgrad Med; 2000 Sep; 108(3 Suppl):22-8. PubMed ID: 19667527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
    Savi L; Mogavero S; Egan CG
    Drug Des Devel Ther; 2014; 8():983-92. PubMed ID: 25092964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
    Solomon S; Frishberg B; Hu XH; Markson L; Berger M
    Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M
    CNS Drugs; 2012 Sep; 26(9):791-811. PubMed ID: 22900951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting.
    Baos V; Serrano A; Torrecilla M; Bertral C; Caloto MT; Nocea G; Gerth WC;
    Int J Clin Pract; 2003 Nov; 57(9):761-8. PubMed ID: 14686564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
    Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA
    Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
    Cady R; Martin V; Adelman J; Diamond M; Sajjan S; Hu XH
    Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
    Freitag F; Diamond M; Diamond S; Janssen I; Rodgers A; Skobieranda F
    Headache; 2008 Jun; 48(6):921-30. PubMed ID: 18572432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.
    Colman SS; Brod MI; Krishnamurthy A; Rowland CR; Jirgens KJ; Gomez-Mancilla B
    Clin Ther; 2001 Jan; 23(1):127-45. PubMed ID: 11219473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.
    Krymchantowski AV; Bigal ME
    BMC Neurol; 2004 Jun; 4():10. PubMed ID: 15222892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
    Láinez MJ; Galván J; Heras J; Vila C
    Eur J Neurol; 2007 Mar; 14(3):269-75. PubMed ID: 17355546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.